BEAM position history
The shares of Beam Therapeutics (BEAM) that Duquesne Family Office LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 153,600 shares, $5.3M, 0.10% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|